A joint research and development group has been formed by Samsung Electronics, SK Telecom, and Kakao to develop an artificial intelligence platform that alerts users of coronavirus risks in advance.
According to the companies Tuesday, the group aims to introduce the platform by early next year.
The AI model gathers foot traffic big data, public disaster data, and social media information and calculates an accurate risk level by region, and offers safe, alternative travel routes to users.
It also provides a customized alert service to users with data saved in their smartphones, such as flight bookings and hotel reservations.
Key functions and technologies of the AI platform will be accessible by the public, developers, research institutions, and private companies.


TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling
Boeing Reaches Tentative Settlement With Canadian Victim’s Family in 737 MAX Crash Lawsuits
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 



